László Tamás

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial

Denis Soulières, Sandrine Faivre, Éva Remenár et al. · The Lancet Oncology · 2017 · 214 citations

Placebo-controlled Phase 2, Neoadjuvant Therapy, Medicine +7

Depression scores and quality of life of vertiginous patients, suffering from different vestibular disorders

András Molnár, Stefani Maihoub, Panayiota Mavrogeni et al. · European Archives of Oto-Rhino-Laryngology · 2022 · 46 citations · Full text

Accuracy of the preoperative diagnostic workup in patients with head and neck cancers undergoing neck dissection in terms of nodal metastases

Angéla Horváth, Péter Prekopp, Gábor Polony et al. · European Archives of Oto-Rhino-Laryngology · 2020 · 40 citations · Full text

Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer

Ede Birtalan, Kornél Dános, Bianka Gurbi et al. · Applied immunohistochemistry & molecular morphology · 2017 · 38 citations

Cancer Immunosurveillance, Pd-l1 Expression, Hypopharyngeal Cancer +14

Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas

Gabriella Szentkúti, Kornél Dános, Diána Brauswetter et al. · Pathology & Oncology Research · 2014 · 36 citations

Regional Biomarker Profiles, Prognostic Biomarkers, Correlations Between Prognosis +9